Hrmy earnings
WebUpgrade to Premium to see how . HRMY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks. Try It for Just $1. ... HRMY price to earnings (PE)For valuing profitable companies with steady earnings. Company. 10.87x. Industry. 18.17x. Market. 21.81x. Web12 apr. 2024 · Key profitability statistics from the latest earnings report; HRMY income statement (TTM) Revenue: US$437.86m: Cost of Revenue: US$83.48m: Gross Profit: …
Hrmy earnings
Did you know?
WebHarmony Biosciences Holdings, Inc. (HRMY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate … Web11 apr. 2024 · Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) has a higher price-to-earnings ratio of 10.67x compared to its average ratio, Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 as “hold,” and 0 as “
WebHarmony Biosciences Holdings (HRMY) will release its next earnings report on May 9, 2024. In the last quarter Harmony Biosciences Holdings reported $0.584 EPS in relation … WebHRMY: Harmony Biosciences Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research.
Web21 mrt. 2024 · The price-to-earnings ratio for Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) is above average at 14.83x, Analysts have differing opinions on the stock, with 6 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 … Web29 mrt. 2024 · HRMY Harmony Biosciences Holdings Inc. Analyst Estimates & Rating – WSJ Harmony Biosciences Holdings Inc. HRMY (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/29/23 $33.36 USD...
WebOverview Forecast Earnings Dividend Ownership Analyst price target for HRMY All Analysts Top Analysts Based on 6 analyst s offering 12 month price targets for Harmony Biosciences Holdings Inc. Min Forecast $43.00 +40.98% Avg Forecast $60.50 +98.36% Max Forecast $70.00 +129.51% Should I buy or sell HRMY stock? All Analysts Top …
Web24 feb. 2024 · NASDAQ:HRMY Harmony Biosciences - HRMY News Today $45.33 -0.77 (-1.67%) (As of 02/24/2024 12:00 AM ET) Compare Today's Range $44.46 $46.77 50-Day Range $43.81 $57.25 52-Week Range $33.04 $62.08 Volume 658,102 shs Average Volume 591,228 shs Market Capitalization $2.70 billion P/E Ratio 15.26 Dividend Yield N/A Price … ksna outgoing flightsWeb6 apr. 2024 · Harmony Biosciences Holdings, Inc. (HRMY) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. ksn bin credit card numberWeb13 apr. 2024 · Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) ... The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.47. ksna weatherWeb1 dag geleden · In 2024, HRMY's revenue was $437.86 million, an increase of 43.35% compared to the previous year's $305.44 million. Earnings were $181.47 million, an … ksnawymp001s:2443/swp/group/accessWebTable displays both upcoming quarterly earnings dates and historical release dates. ... (HRMY). Stocks Features Premarket Trading After Hours Trading Market Movers 52-Week Highs & Lows Stock Order Imbalance Unusual Stock … ksnb news teamWeb28 feb. 2024 · Mar 06, 2024. PLYMOUTH MEETING, Pa. , March 6, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a … ksn attorney chicagoWebHRMY Earnings Forecast Next quarter’s earnings estimate for HRMY is $0.49 with a range of $0.41 to $0.62. The previous quarter’s EPS was $0.79. HRMY beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.39% of the time in the same period. ksnb news anchors